579 related articles for article (PubMed ID: 9388531)
1. [TNM classification of malignant melanoma and non-melanoma skin cancer].
Suzuki T; Inoue Y; Kiyohara Y; Ikeda S
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2163-9. PubMed ID: 9388531
[TBL] [Abstract][Full Text] [Related]
2. Deep learning data augmentation for Raman spectroscopy cancer tissue classification.
Wu M; Wang S; Pan S; Terentis AC; Strasswimmer J; Zhu X
Sci Rep; 2021 Dec; 11(1):23842. PubMed ID: 34903743
[TBL] [Abstract][Full Text] [Related]
3. Altered endosomal-lysosomal biogenesis in melanoma.
Lam GT; Sorvina A; Martini C; Prabhakaran S; Ung BS; Lazniewska J; Moore CR; Beck AR; Hopkins AM; Johnson IRD; Caruso MC; Hickey SM; Brooks RD; Jackett L; Karageorgos L; Foster-Smith EJ; Malone V; Klebe S; O'Leary JJ; Brooks DA; Logan JM
Neoplasia; 2023 Sep; 43():100924. PubMed ID: 37562257
[TBL] [Abstract][Full Text] [Related]
4. Spatial analysis of photoplethysmography in cutaneous squamous cell carcinoma.
Rasmussen SM; Nielsen T; Hager H; Schousboe LP
Sci Rep; 2022 May; 12(1):7318. PubMed ID: 35513459
[TBL] [Abstract][Full Text] [Related]
5. An Ensemble Architecture for Melanoma Classification.
Ruga T; Musacchio G; Maurmo D
Stud Health Technol Inform; 2024 May; 314():183-184. PubMed ID: 38785028
[TBL] [Abstract][Full Text] [Related]
6. Letter to the editors: Development of malignant melanoma and squamous cell carcinoma in a patient receiving fingolimod treatment.
Karabas M; Tepe N; Esmeli F
Neurol Sci; 2024 Jan; 45(1):359-360. PubMed ID: 37723372
[No Abstract] [Full Text] [Related]
7. Critical determinants of melanoma metastasis.
Fidler IJ
J Investig Dermatol Symp Proc; 1996 Apr; 1(2):203-8. PubMed ID: 9627717
[TBL] [Abstract][Full Text] [Related]
8. Definition of unique and shared T-cell defined tumor antigens in human renal cell carcinoma.
Brouwenstijn N; Hoogstraten C; Verdegaal EM; Van der Spek CW; Deckers JG; Mulder A; Osanto S; Schrier PI
J Immunother; 1998 Nov; 21(6):427-34. PubMed ID: 9807737
[TBL] [Abstract][Full Text] [Related]
9. Ovarian small cell tumors: an electron microscopic review.
Dickersin GR; Scully RE
Ultrastruct Pathol; 1998; 22(3):199-226. PubMed ID: 9793201
[TBL] [Abstract][Full Text] [Related]
10. Influence of hepatocyte growth factor/scatter factor on the metastatic phenotype of B16 melanoma cells.
Rusciano D; Lin S; Lorenzoni P; Casella N; Burger MM
Tumour Biol; 1998; 19(5):335-45. PubMed ID: 9701724
[TBL] [Abstract][Full Text] [Related]
11. Skin cancer and actinic keratoses.
Ruskiewicz J
J Am Optom Assoc; 1998 Apr; 69(4):229-35. PubMed ID: 9585662
[TBL] [Abstract][Full Text] [Related]
12. Differential response of human melanoma and Ehrlich ascites cells in vitro to the ribosome-inactivating protein luffin.
Poma A; Miranda M; Spanò L
Melanoma Res; 1998 Oct; 8(5):465-7. PubMed ID: 9835461
[TBL] [Abstract][Full Text] [Related]
13. Comparison of high dose rate, low dose rate, and high dose rate fractionated radiation for optimizing differences in radiosensitivities in vitro.
Wilkins RC; Ng CE; Raaphorst GP
Radiat Oncol Investig; 1998; 6(5):209-15. PubMed ID: 9822167
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2.
Seidel MG; Freissmuth M; Pehamberger H; Micksche M
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):382-9. PubMed ID: 9774227
[TBL] [Abstract][Full Text] [Related]
15. Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution.
Hofbauer GF; Kamarashev J; Geertsen R; Böni R; Dummer R
Melanoma Res; 1998 Aug; 8(4):337-43. PubMed ID: 9764809
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic node dissections in malignant melanoma.
Karakousis CP
Ann Surg Oncol; 1998 Sep; 5(6):473-82. PubMed ID: 9754754
[TBL] [Abstract][Full Text] [Related]
17. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients.
Quinn MJ; Crotty KA; Thompson JF; Coates AS; O'Brien CJ; McCarthy WH
Cancer; 1998 Sep; 83(6):1128-35. PubMed ID: 9740077
[TBL] [Abstract][Full Text] [Related]
18. TALL-104 cell therapy of human solid tumors implanted in immunodeficient (SCID) mice.
Cesano A; Visonneau S; Santoli D
Anticancer Res; 1998; 18(4A):2289-95. PubMed ID: 9703868
[TBL] [Abstract][Full Text] [Related]
19. Melanocytic naevus or malignant melanoma? A large-scale epidemiological study of diagnostic accuracy.
Lindelöf B; Hedblad MA; Sigurgeirsson B
Acta Derm Venereol; 1998 Jul; 78(4):284-8. PubMed ID: 9689297
[TBL] [Abstract][Full Text] [Related]
20. Melanoma-cell toxicity of cystemustine combined with O6-benzyl-N2-acetylguanosine.
Buchdahl C; Rolhion C; Glasser AL; Debiton E; Mounetou E; Madelmont JC; Laval F
Melanoma Res; 1998 Apr; 8(2):123-30. PubMed ID: 9610864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
